Kite Announces New Data Analyses for CAR T Therapy in Patients with Blood Cancers at the 2018 American Society of … – Taiwan News
Taiwan News |
Kite Announces New Data Analyses for CAR T Therapy in Patients with Blood Cancers at the 2018 American Society of …
Taiwan News CHICAGO–(BUSINESS WIRE)–Jun 4, 2018–Kite, a Gilead Company (Nasdaq: GILD), today announced new analyses from the ZUMA chimeric antigen receptor T (CAR T) cell therapy development program that are being presented at the 2018 American … |
